RespireRx Pharmaceuticals Inc (fka RSPI)

[DewDiligence]

>If Cortex decides to proceed with a registered direct offering, how much information do you think Cortex would have to provide to the prospective investors in regards to potential/expected timeframes for an RD deal, and the ballpark expected magnitude of an RD deal? I'd think the investors would want to have a decent handle on the RD deal prospects before plunking down their cash, so I'm curious how much Cortex would likely be willing to share with them.<

Unless the prospective buyers sign a non-disclosure agreement, COR cannot legally disclose anything of consequence to them that is not already in the SEC filings.

Non-disclosure agreements are generally reserved for major strategic transactions; they are rarely if ever used for routine financing deals. Regards, Dew